Comparative Pharmacology
Head-to-head clinical analysis: METHADONE HYDROCHLORIDE INTENSOL versus METHADOSE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADONE HYDROCHLORIDE INTENSOL versus METHADOSE.
METHADONE HYDROCHLORIDE INTENSOL vs METHADOSE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist. It also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake. Its long duration of action is due to high protein binding and tissue sequestration.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
Oral: 2.5-10 mg every 8-12 hours; titrate slowly. Typical adult dose: 5-10 mg PO every 8-12 hours.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
None Documented
None Documented
Terminal elimination half-life ranges from 15 to 60 hours (mean ~24-36 hours). The long half-life allows for once-daily dosing in maintenance therapy but risk of accumulation and delayed toxicity during initiation.
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Methadone is primarily eliminated via feces (about 50-60%) and urine (about 20-30%), with approximately 10% as unchanged drug in urine. Biliary excretion contributes to fecal elimination.
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Category D/X
Category C
Opioid Agonist
Opioid Agonist